Antigenic determinants in the N-terminal part of bovine encephalitogenic protein studied with the macrophage migration inhibition assay in guinea pigs. Evidence for an immunological reactivity of peptide 1-43 when tested on cells from animals injected with Freunds's complete adjuvant

Effect of encephlitogenic protein. PPD and tetanus toxoid on leukocyte migration in agarose. A study of "cross-reactivity"

The reactivity to three antigens: bovine encephalitogenic protein (EP), PPD, and tetanus toxoid, was studied with blood leukocytes from healthy humans using Clausen's (5) leukocyte migration in agarose technique. There is an obvious correlation between the reaction of EP (all concentrations studied) and to low concentrations of PPD; and between the reactivity to low concentrations of EP and low concentrations of tetanus toxoid. After vaccination with tetanus vaccine, a marked increase in reactivity to the toxoid sometimes occurred; at the same time, a marked reactivity to EP appeared. Various explanations are discussed: a true immunological cross-reactivity, that the correlations are due to a variability in individual response with respect to lymphokine production, and that BCG and tetanus vaccinations produce an adjuvant effect increasing a pre-existing low reactivity to EP.

Bovine myelin basic protein: immunochemical specificity examined by the macrophage migration inhibition test

Guinea pigs were injected with saline or with one of the following antigens incorporated into Freund's complete adjuvant: Bovine myelin basic protein (MBP), lysozyme, carboxymethylated lysozyme, or a crude commercial calf thymus histone preparation. Examination of the migration of peritoneal cells from these animals in the presence (50 microgram/ml) or the absence of the antigens revealed, at most, a slight one-way form of cross-reactivity between MBP on the one hand and the histone preparation--and possibly also lysozyme--on the other. This was observed only with cells from animals injected with the two last-mentioned antigens. Cells from animals sensitized with either histone or lysozyme mixed with poly AU instead of Freund's complete adjuvant were also slightly inhibited in their migration by the bovine MBP. Cells from animals injected with complete Freund's adjuvant alone or with the purified protein derivative of tuberculin (PPD) in poly AU did not react to MBP. Thus, in contrast to the high degree of internal cross-reactivity shown previously MBP shows a low degree of cross-reactivity with either ordered or unordered forms of some unrelated basic proteins.

Encephalitogenic activity of the N-terminal part of bovine myelin basic protein in rabbits

The disease-inducing activity of the N-terminal part (residues 1-42) of bovine myelin basic protein in rabbits is localized to two regions. One encephalitogenic determined probably incorporates at least one of the lysine residues (Nos. 4 and 11); the other is within residues 20-36. It is concluded that region 1-42 shows a comparably strong degree of encephalitogenicity for rabbits.

Effect of encephalitogenic protein on the migration in agarose of leucocytes from patients with multiple sclerosis. Correlations with clinical parameters, localization of antigenic determinants, and influence of corticotrophin treatment

We have extended the results from our previous investigation of the reactivity of leucocytes from patients with multiple sclerosis and some other neurological diseases to bovine encephalitogenic protein, using the migration in agarose technique. 1. Reactivity (i.e. behaviour in the test deviating from that expected with cells from healthy subjects) is manifested either as an enhancement or an inhibition of leucocyte migration. 2. The incidence of subjects with cells showing reactivity to encephalitogenic protein is higher in the group of patients with multiple sclerosis than in the group of patients with other neurological diseases. 3. Reactivity to encephalitogenic protein is correlated to disease course score; patients with a chronic progression of the disease show the strongest reactivity in the test. 4. The tryptophan-containing region of the encephalitogenic protein appears to be a major determinant of significance for this test. 5. Patients tested during corticotrophin treatment tend to show a higher degree of reactivity in the test than expected-the increased reactivity seems to be primarily directed to the tryptophan-containing region.